OCTP.L

Oxford Cannabinoid Technologies Holdings Plc
Oxford Cannabinoid - Updated Shareholder Engagement
31st May 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 5498Q
Oxford Cannabinoid Tech.Holdings
31 May 2024
 

 

Oxford Cannabinoid Technologies Holdings plc

("OCT" or the "Company")

 

Updated Shareholder Engagement following Listing Cancellation

 

The Board of Oxford Cannabinoid Technologies Holdings plc (LSE:OCTP) refers to its announcements of 8 May 2024 and 17 May 2024. 

On 8 May, the Company said it was exploring the implementation of a Matched Bargain Facility after the cancellation of listing of its ordinary shares on the Standard segment of the FCA's Official List and trading on the Main Market for listed securities of the LSE (Cancellation).

The Board has concluded that it is not practicable in the short term to put in place such a facility but, following the Cancellation, in the event that there are any changes to this, details will be made available to shareholders on the Company's website at www.oxcantech.com

The Cancellation will become effective at 8.00am on 6 June 2024,

The Directors of the Company accept responsibility for the content of this announcement.

 

Enquiries:

Oxford Cannabinoid Technologies Holdings plc

+44 (0)20 3034 2820

Clarissa Sowemimo-Coker (CEO)

clarissa@oxcantech.com



Hybridan LLP, Financial Adviser and Broker


Claire Louise Noyce

+44 (0)20 3764 2341



Acuitas Communications, Financial PR

+44 (0)20 3745 0293 / 07799 767676

Simon Nayyar

simon.nayyar@acuitascomms.com

Arthur Dingemans

arthur.dingemans@acuitascomms.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAPSEDFSLEFA]]>
TwitterFacebookLinkedIn